Pembrolizumab targets a specific protein on immune cells to destroy cancerous cells, showing potential in a global trial.
Prof Javier Cortes noted a significant increase in the lack of cancer cells in the breast or lymph nodes among those treated with pembrolizumab.
[
add
]
[
|
|
...
]